DNA and Gene Cloning Services Market worth $12.15 Billion by 2030

JERSEY CITY, NJ, Aug 25, 2022 /PRNewswire/ — InsightAce Analytic Pvt. ltd has announced the publication of a market research report titled “Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2030” According to company’s newest research, the Global DNA and Gene Cloning Services Market is worth US$2.80 trillion in 2021 and is predicted to reach US$12.15 trillion in 2030, with a promising CAGR of 18.22% between 2022 and 2030.

InsightAce Analytic logo

Get a Demo Sample copy of the Global DNA and Gene Cloning Services Market Report at https://www.insightaceanalytic.com/request-sample/1357

Many scientific processes begin with gene synthesis and cloning. DNA amplification by subcloning and polymerase chain reaction are two standard techniques for genetic cloning. The method of DNA cloning is simply recombinant DNA technology, which combines DNA from two organisms into a single molecule. This recombinant DNA is inserted into the desired organism to produce hybrid offspring. DNA cloning is used for protein production, gene analysis, and gene therapy. The method of cloning genes involves isolating all of an organism’s DNA and then locating and copying (or “cloning”) a specific gene of interest from that DNA. DNA cloning includes DNA extraction of plasmid, restriction enzymes, and a living cell for multiplication of newly formed DNA. Polymerase chain reaction(PCR) is widely used for cloning purposes. In genetic engineering, “gene cloning” refers to creating synthetic copies of a gene. Cloning genes can be done in two ways, in vivo and in vitro. Many human genes have been successfully cloned in E. coli or yeast, enabling the production of an infinite number of human proteins in vitro. More than 100 drugs for human therapy are manufactured using cultured cells (E. coli, yeast, and mammalian cells) modified with a human gene. Cloning is a revolutionary technique in the field of biotechnology. It is helping humanity in several ways, and many chronic diseases are being treated using this technique, increasing the lifespan. A healthy and better life is achieved due to this genetic development. In agricultural applications, crops are being improved daily, leading to better nutritious values.

The market for DNA and gene cloning services is expected to grow progressively in the coming years. This is due to the growing acceptance of gene therapies and the development and application of novel, cutting-edge DNA cloning technology. These two things will be likely to drive the market for DNA and gene cloning services. The market is also propelled by an increase in the number of firms entering the area and spending on research and development, the rising prevalence of chronic and hereditary diseases, coupled with a growing need for personalized medicine. A favorable funding framework for gene synthesis and cloning services, technological advancements in cloning and subcloning services, and increased synergistic market activities are among the aspects driving the industry’s expansion during the forecast period.

In the coming years, the worldwide market for gene synthesis may be hampered by a lack of qualified personnel and rigorous and time-consuming approval procedures. Technological advancements, strategic partnerships, and acquisitions in the biomedical and healthcare industries might present the market with intriguing opportunities. However, high investments, funding, and collaborations for industrial growth are expected in the projection period as NorthAmerica prioritizes the usage of DNA and Gene Cloning in the life science research industry.

The significant market companies are Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad, and other key players.

Curious about this latest version of the report? For More Information @ https://www.insightaceanalytic.com/customization/1357

Key developments in the market

  • In Jan 2021, Codex DNA and Pfizer signed an early access collaboration and licensing agreement, which will allow Pfizer to use CodexDNA’s novel enzymatic DNA synthesis technology in its research and development of mRNA-based vaccines and biotherapies. Codex DNA will be responsible for further developing the technology.

  • In May 2020, GenScript just launched a GMP single-strand and double-strand DNA service to aid in the growth of genes and cell therapies. The announcement highlights GenScript’s commitment to assisting entire non-viral cell therapy development through the IND-enabling and clinical stages.

  • In Dec 2020, ThermoFisher increased its plasmid DNA manufacturing clinical and commercial capabilities. Commercialization of plasmid-based drugs and vaccines will be accelerated by the opening of a new cGMP facility in Carlsbad, California. The facility will also be able to generate large amounts of plasmid DNA, which is a crucial component of drugs used in DNA treatments. This growth builds on the business’s ongoing commitment to providing cell and gene therapy services.

  • In May 2020, Takara Bio announced a collaboration with AGC Biologics. The businesses will collaborate on a prophylactic DNA vaccine against COVID-19, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.

Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1357

Market segmentation:

Global DNA and Gene Cloning Services Market, by Type of Service Offered2022-2030 (Value US$Mn)

  • Custom cloning

  • gene synthesis

  • Subcloning

  • Others

Global DNA and Gene Cloning Services Market, by Type of genes2022-2030 (Value US$Mn)

  • complex genes

  • default genes

  • Others

Global DNA and Gene Cloning Services Market, by End User Industry2022-2030 (Value US$Mn)

Global DNA and Gene Cloning Services Market, by region2022-2030 (Value US$Mn)

  • NorthAmerica

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

North America DNA and Gene Cloning Services Market, by Country2022-2030 (Value US$Mn)

Europe DNA and Gene Cloning Services Market, by Country2022-2030 (Value US$Mn)

  • Germany

  • France

  • Italy

  • Spain

  • Russia

  • rest of Europe

Asia Pacific DNA and Gene Cloning Services Market, by Country2022-2030 (Value US$Mn)

  • India

  • China

  • Japan

  • south korea

  • Australia & New Zealand

Latin America DNA and Gene Cloning Services Market, by Country2022-2030 (Value US$Mn)

  • Brazil

  • Mexico

  • rest of Latin America

Middle East & Africa DNA and Gene Cloning Services Market, by Country2022-2030 (Value US$Mn)

For More Information @ https://www.insightaceanalytic.com/customization/1357

Other Related Reports Published by InsightAce Analytic:

Global Cell and Gene Therapy Drug Delivery Devices Market

Global Circulating Cell-Free DNA (ccfDNA) Diagnostics Market

Global Cell and Gene Therapy Bioassay Services Market

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for the global DNA and Gene Cloning Services Market

  • To receive an industry overview and future trends of the DNA and Gene Cloning Services Market

  • To analyze DNA and Gene Cloning Services Market drivers and challenges

  • To get information on the DNA and Gene Cloning Services Market size (Value US$ Mn) forecast to 2030

  • To get information on significant investments, mergers & acquisitions in the DNA and Gene Cloning Services Market industry

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:
InsightAce Analytic Pvt. ltd
Tel: +1 551 226 6109
Email: info@insightaceanalytic.com
Site visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg



View original content:https://www.prnewswire.com/news-releases/dna-and-gene-cloning-services-market-worth-12-15-billion-by-2030—exclusive-report-by- insightace-analytic-301612427.html

SOURCE InsightAce Analytic Pvt. ltd

Leave a Reply

%d bloggers like this: